Study of Oral Papillomavirus In Teens and Twenties

Recently human papillomavirus (HPV) has been recognized to cause some oropharyngeal (tonsil) cancer. But very little is known about oral HPV infection and risk factors. This study will evaluate how common oral HPV infection is, what sexual behaviors are associated with risk for infection, and how long infections tend to last.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

STD Head and Neck Neoplasms Mouth Diseases Mouth Neoplasms Neoplasms Neoplasms by Site Stomatognathic Diseases

Age range

18 year–26 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Baltimore County Eastern Health Center, Baltimore, Maryland, United States

About this study

18-25 year old individuals are being recruited from STD clinics in Baltimore County and followed every three months for this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 -26 years

Exclusion criteria

Never received HPV vaccine (Gardasil or Cervarix)

Treatment and study plan

Primary outcomes

Oral HPV infection

Time frame: 24 months

Oral rinse samples collected prospectively for 24 months

Sponsors and collaborators

Lead sponsor

Johns Hopkins Bloomberg School of Public Health

Other

Registry information

Official study title

Short-term Natural History of Oral HPV Infection Among Young Adults

Acronym: SPITT

Important dates

Study start: 2010
Primary completion: 2014
Study completion: 2014
First posted: Oct 14, 2009
Registry last updated: Jan 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed